1. Hong, Weijun, Xue, Min, Jiang, Jun, Zhang, Yajuan, Gao, Xiwen. 2020. Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC). In Journal of experimental & clinical cancer research : CR, 39, 149. doi:10.1186/s13046-020-01648-1. https://pubmed.ncbi.nlm.nih.gov/32746878/
2. Wang, Kongjia, Ding, Yixin, Liu, Yunbo, Jiang, Bo, Hou, Sichuan. . CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells. In Journal of cellular and molecular medicine, 28, e18165. doi:10.1111/jcmm.18165. https://pubmed.ncbi.nlm.nih.gov/38494845/
3. Kayashima, Tomohiko, Yamasaki, Kentaro, Yamada, Takahiro, Niikawa, Norio, Kishino, Tatsuya. 2003. The novel imprinted carboxypeptidase A4 gene ( CPA4) in the 7q32 imprinting domain. In Human genetics, 112, 220-6. doi:. https://pubmed.ncbi.nlm.nih.gov/12552318/
4. Lei, Chang-Gui, Jia, Xue-Yuan, Sun, Wen-Jing. . Establish six-gene prognostic model for glioblastoma based on multi-omics data of TCGA database. In Yi chuan = Hereditas, 43, 665-679. doi:10.16288/j.yczz.20-428. https://pubmed.ncbi.nlm.nih.gov/34284982/
5. Sun, Lichao, Wang, Yipeng, Yuan, Hebao, Myers, Ila, Sun, Duxin. 2016. CPA4 is a Novel Diagnostic and Prognostic Marker for Human Non-Small-Cell Lung Cancer. In Journal of Cancer, 7, 1197-204. doi:10.7150/jca.15209. https://pubmed.ncbi.nlm.nih.gov/27390594/
6. Gao, Weinian, Guo, Na, Zhao, Shuguang, Liao, Hongjuan, Chi, Kui. . Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling. In Bioscience reports, 40, . doi:10.1042/BSR20200669. https://pubmed.ncbi.nlm.nih.gov/32347291/
7. Ross, Phillip L, Cheng, Iona, Liu, Xin, Casey, Graham, Witte, John S. 2009. Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. In BMC cancer, 9, 69. doi:10.1186/1471-2407-9-69. https://pubmed.ncbi.nlm.nih.gov/19245716/
智鼠故事 
